NCT02100839View on ClinicalTrials.gov

Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions
HypercholesterolemiaHyperlipoproteinemia Type II
Interventions
DRUG

AEM-28

Solution for injection

DRUG

Normal Saline

0.9% saline for injection

Trial Locations (1)

6009

Linear Clinical Research Ltd., Nedlands

Sponsors
All Listed Sponsors
lead

LipimetiX Development, LLC

INDUSTRY

NCT02100839 - Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia | Biotech Hunter | Biotech Hunter